Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease: a real-world case series. Farkouh A, Nathoo-Khedri N, Dufresne A, Danaie H, et al. J Crohns Colitis 2026;20:jjag089.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Farkouh A, Nathoo-Khedri N, Dufresne A, Danaie H, et al. Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease: a real-world case series. J Crohns Colitis 2026;20:jjag089.
PMID: 42357950